Literature DB >> 25431830

Functional ability level development and validation: providing clinical meaning for Spinal Cord Injury Functional Index scores.

Richa Sinha1, Mary D Slavin2, Pamela A Kisala3, Pengsheng Ni2, David S Tulsky4, Alan M Jette2.   

Abstract

OBJECTIVES: To develop functional ability levels for the Spinal Cord Injury Functional Index (SCI-FI) and to validate them using calibration and reliability samples.
DESIGN: Three-phase strategy involved (1) performing quantitative synthesis of SCI-FI data to create item maps; (2) using a panel of experts to identify functional ability levels after the bookmarking and Delphi consensus-building process; and (3) performing quantitative analyses to examine demographic characteristics across 2 samples, assessing the distribution pattern across functional ability levels, and examining concurrent validity using the self-reported functional measure and the observer-rated FIM.
SETTING: Inpatient and community settings. PARTICIPANTS: People 18 years or older with traumatic spinal cord injury (N=1124) were recruited from the Spinal Cord Injury Model Systems programs and stratified by diagnosis, severity, and time since injury (n=855 and n=269 for calibration and reliability samples, respectively).
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURE: SCI-FI.
RESULTS: Five functional ability levels were identified for all SCI-FI domains, except fine motor having 4 functional ability levels. Statistical test results indicated no significant differences in the distribution pattern across the 2 samples across functional ability levels for all domains except for ambulation. Known-group comparisons were able to discern the spinal cord injury population as expected. Basic mobility, self-care, and wheelchair mobility domains had a cluster of persons with paraplegia and incomplete lesions at higher functional ability levels and persons with tetraplegia and complete lesions at lower functional ability levels. For the ambulation domain, the distribution was skewed to the lower end, with a relatively small percentage of persons with incomplete lesions (paraplegia and tetraplegia) at higher functional ability levels. For the fine motor domain, the distribution was skewed to higher functional ability levels, with a high percentage of persons with paraplegia at the highest level (complete and incomplete lesions). Concurrent validity analyses revealed SCI-FI functional levels to be significantly (P<.001) positively correlated with both the self-reported functional measure and the observer-rated FIM.
CONCLUSIONS: Clinicians can use functional ability levels to discuss patients' functional capabilities with them and their family.
Copyright © 2015 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Disability evaluation; Patient outcome assessment; Rehabilitation; Spinal cord injuries

Mesh:

Year:  2014        PMID: 25431830     DOI: 10.1016/j.apmr.2014.11.008

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  3 in total

1.  Clinical interpretation of the Spinal Cord Injury Functional Index (SCI-FI).

Authors:  Denise Fyffe; Claire Z Kalpakjian; Mary Slavin; Pamela Kisala; Pengsheng Ni; Steven C Kirshblum; David S Tulsky; Alan M Jette
Journal:  J Spinal Cord Med       Date:  2016-02-05       Impact factor: 1.985

2.  Body System Effects of a Multi-Modal Training Program Targeting Chronic, Motor Complete Thoracic Spinal Cord Injury.

Authors:  Katie L Gant; Kathleen G Nagle; Rachel E Cowan; Edelle C Field-Fote; Mark S Nash; Jochen Kressler; Christine K Thomas; Mabelin Castellanos; Eva Widerström-Noga; Kimberly D Anderson
Journal:  J Neurotrauma       Date:  2017-10-16       Impact factor: 5.269

3.  Interpreting Life Impact Burn Recovery Evaluation Profile Scores for Use by Clinicians, Burn Survivors, and Researchers.

Authors:  Mary D Slavin; Colleen M Ryan; Jeffrey C Schneider; Amy Acton; Flor Amaya; Cayla Saret; Emily Ohrtman; Audrey Wolfe; Pengsheng Ni; Lewis E Kazis
Journal:  J Burn Care Res       Date:  2021-02-03       Impact factor: 1.845

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.